CVE-2022-38111

SolarWinds Platform Deserialization of Untrusted Data Vulnerability

Description

SolarWinds Platform was susceptible to the Deserialization of Untrusted Data. This vulnerability allows a remote adversary with Orion admin-level account access to SolarWinds Web Console to execute arbitrary commands.

Remediation

Solution:

  • All SolarWinds Platform customers are advised to upgrade to the latest version of the SolarWinds Platform version 2023.1

Category

7.2
CVSS
Severity: High
CVSS 3.1 •
EPSS 24.28% Top 5%
Vendor Advisory solarwinds.com Vendor Advisory solarwinds.com
Affected: SolarWinds SolarWinds Platform
Published at:
Updated at:

References

Link Tags
https://documentation.solarwinds.com/en/success_center/orionplatform/content/release_notes/solarwinds_platform_2023-1_release_notes.htm vendor advisory
https://www.solarwinds.com/trust-center/security-advisories/CVE-2022-38111 vendor advisory

Frequently Asked Questions

What is the severity of CVE-2022-38111?
CVE-2022-38111 has been scored as a high severity vulnerability.
How to fix CVE-2022-38111?
To fix CVE-2022-38111: All SolarWinds Platform customers are advised to upgrade to the latest version of the SolarWinds Platform version 2023.1
Is CVE-2022-38111 being actively exploited in the wild?
It is possible that CVE-2022-38111 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~24% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2022-38111?
CVE-2022-38111 affects SolarWinds SolarWinds Platform.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.